4.7 Editorial Material

Success and Challenges Associated with Large-Scale Collaborative Surveillance for Carbapenemase Genes in Gram-Negative Bacteria

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Immunology

Multispecies Outbreak of Verona Integron-Encoded Metallo-β-Lactamase-Producing Multidrug-Resistant Bacteria Driven by a Promiscuous Incompatibility Group A/C2 Plasmid

Tom J. B. de Man et al.

Summary: This investigation identified the largest known outbreak of VIM-producing CRE in the United States, showcasing evidence of in-hospital plasmid transmission and environmental contamination.

CLINICAL INFECTIOUS DISEASES (2021)

Article Infectious Diseases

Assessing the in vitro impact of ceftazidime on aztreonam/avibactam susceptibility testing for highly resistant MBL-producing Enterobacterales

Amelia Bhatnagar et al.

Summary: This study aimed to determine whether increasing ceftazidime concentrations affect the MICs of aztreonam/avibactam. Testing on 37 Enterobacteriales isolates with intermediate or resistant interpretations to aztreonam and ceftazidime/avibactam showed that ceftazidime did not affect the in vitro activity of aztreonam/avibactam in the combination.

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2021)

Article Microbiology

Aztreonam-Avibactam Susceptibility Testing Program for Metallo-Beta-Lactamase-Producing Enterobacterales in the Antibiotic Resistance Laboratory Network, March 2019 to December 2020

Amelia Bhatnagar et al.

Summary: Aztreonam-avibactam, a drug combination currently in phase 3 clinical trials, has shown potent in vitro activity against metallo-beta-lactamase (MBL)-producing Enterobacterales.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2021)

Article Infectious Diseases

Carbapenemase production among less-common Enterobacterales genera: 10 US sites, 2018

Alicia Shugart et al.

Summary: Less common genera (LCG) play a significant role in carbapenemase-producing CRE, with Citrobacter spp. being a common CP-LCG. Testing mechanisms in additional genera could improve detection and prevention efforts for CP-CRE.

JAC-ANTIMICROBIAL RESISTANCE (2021)

Article Immunology

Infectious Diseases Society of America Guidance on the Treatment of Extended-Spectrum β-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa)

Pranita D. Tamma et al.

Summary: This guidance document provides recommendations for the treatment of antimicrobial-resistant infections caused by ESBL-E, CRE, and DTR-P. aeruginosa, with a focus on the United States. It discusses empiric treatment selection, duration of therapy, and other management considerations for both adults and children. The current version of the guidance is valid as of September 17, 2020, and will be updated periodically.

CLINICAL INFECTIOUS DISEASES (2021)

Article Microbiology

Coinfections of Two Strains of NDM-1-and OXA-232-Coproducing Kiebsiella pneumoniae in a Kidney Transplant Patient

Deisy A. Contreras et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)

Article Microbiology

Validation of Aztreonam-Avibactam Susceptibility Testing Using Digitally Dispensed Custom Panels

Eric Ransom et al.

JOURNAL OF CLINICAL MICROBIOLOGY (2020)

Article Microbiology

Antibiotic Susceptibility of NDM-Producing Enterobacterales Collected in the United States in 2017 and 2018

Joseph D. Lutgring et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)

Review Infectious Diseases

Present and Future of Carbapenem-resistant Enterobacteriaceae (CRE) Infections

Beatriz Suay-Garcia et al.

ANTIBIOTICS-BASEL (2019)

Article Public, Environmental & Occupational Health

Vital Signs: Containment of Novel Multidrug-Resistant Organisms and Resistance Mechanisms — United States, 2006–2017

Kate Russell Woodworth et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2018)

Article Public, Environmental & Occupational Health

Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae from Less Common Enterobacteriaceae Genera - United States, 2014-2017

Maroya S. Walters et al.

MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2018)

Article Infectious Diseases

Risk factors and outcomes for multidrug-resistant Gram-negative bacilli bacteremia

Swati Patolia et al.

THERAPEUTIC ADVANCES IN INFECTIOUS DISEASE (2018)

Article Microbiology

In Vitro Activity of Aztreonam-Avibactam against a Global Collection of Gram-Negative Pathogens from 2012 and 2013

Douglas J. Biedenbach et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)

Review Infectious Diseases

Double- and multi-carbapenemase-producers: the excessively armored bacilli of the current decade

G. Meletis et al.

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2015)

Letter Public, Environmental & Occupational Health

The Carbapenemase Menace: Do Dual Mechanisms Code for More Resistance?

Mubin Kazi et al.

INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2015)

Article Infectious Diseases

KPC-PRODUCING Serratia marcescens IN A HOME-CARE PATIENT FROM RECIFE, BRAZIL

Emmily Margate et al.

REVISTA DO INSTITUTO DE MEDICINA TROPICAL DE SAO PAULO (2015)

Article Pharmacology & Pharmacy

Evaluation of the Carba NP Test for Rapid Detection of Carbapenemase-Producing Enterobacteriaceae and Pseudomonas aeruginosa

Nathalie Tijet et al.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)

Review Infectious Diseases

Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases

L. Silvia Munoz-Price et al.

LANCET INFECTIOUS DISEASES (2013)

Review Microbiology

Stormy waters ahead: global emergence of carbapenemases

Gopi Patel et al.

FRONTIERS IN MICROBIOLOGY (2013)

Article Immunology

New Delhi Metallo-β-Lactamase-producing Enterobacteriaceae, United States

J. Kamile Rasheed et al.

EMERGING INFECTIOUS DISEASES (2013)

Review Infectious Diseases

Interventional strategies and current clinical experience with carbapenemase-producing Gram-negative bacteria

M. Akova et al.

CLINICAL MICROBIOLOGY AND INFECTION (2012)